Increasing unusual option volume: GMED TAHO PVH TAP ESPR MAN NGD WFT IRWD DM ADNT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Globus Medical (GMED) PT Raised to $58 at Needham & Company
May 3, 2018 6:38 AM EDTNeedham & Company raised its price target on Globus Medical (NYSE: GMED) to $58.00 (from $57.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "GMED's 1Q18 revenue and EPS beat consensus and management raised its 2018 revenue and EPS guidance. The guidance increases were... More
